Valbiotis (XPAR:ALVAL) Total Stockholders Equity : €19.60 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Valbiotis Total Stockholders Equity?

Valbiotis's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €19.60 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Valbiotis's Book Value per Share for the quarter that ended in Dec. 2023 was €1.24. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Valbiotis's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.35.

Valbiotis Total Stockholders Equity Historical Data

The historical data trend for Valbiotis's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valbiotis Total Stockholders Equity Chart

Valbiotis Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

8.25

7.15

14.30

13.36

19.60

Valbiotis Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial											14.30	9.91	13.36	11.68	19.60

Valbiotis (XPAR:ALVAL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Valbiotis's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(19.6	-	0)	/	15.7733
	=	1.24

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Valbiotis's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.107	+	4.773)	/	19.6
	=	0.35

Valbiotis Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Valbiotis's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Valbiotis (XPAR:ALVAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valbiotis SA (XPAR:ALVAL) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

8JD:Germany

Address

12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180

Website

http://www.valbiotis.com

Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.

Valbiotis (XPAR:ALVAL) Headlines

No Headlines